Muranen, T. A., Chang-Claude, J., & Schneeweiss, A. (2023). PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants. npj Breast cancer, 9, . https://doi.org/10.1038/s41523-023-00546-x
Chicago Style (17th ed.) CitationMuranen, Taru A., Jenny Chang-Claude, and Andreas Schneeweiss. "PREDICT Validity for Prognosis of Breast Cancer Patients with Pathogenic BRCA1/2 Variants." Npj Breast Cancer 9 (2023). https://doi.org/10.1038/s41523-023-00546-x.
MLA (9th ed.) CitationMuranen, Taru A., et al. "PREDICT Validity for Prognosis of Breast Cancer Patients with Pathogenic BRCA1/2 Variants." Npj Breast Cancer, vol. 9, 2023, https://doi.org/10.1038/s41523-023-00546-x.
Warning: These citations may not always be 100% accurate.